{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:44:28Z","timestamp":1773297868516,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,9,10]],"date-time":"2003-09-10T00:00:00Z","timestamp":1063152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1038\/sj.npp.1300296","type":"journal-article","created":{"date-parts":[[2003,9,10]],"date-time":"2003-09-10T14:12:38Z","timestamp":1063203158000},"page":"15-22","source":"Crossref","is-referenced-by-count":28,"title":["Corticotropin-Releasing Hormone (CRH) mRNA Expression in Rat Central Amygdala in Cannabinoid Tolerance and Withdrawal: Evidence for an Allostatic Shift?"],"prefix":"10.1038","volume":"29","author":[{"given":"Laura","family":"Caberlotto","sequence":"first","affiliation":[]},{"given":"Roberto","family":"Rimondini","sequence":"additional","affiliation":[]},{"given":"Anita","family":"Hansson","sequence":"additional","affiliation":[]},{"given":"Siv","family":"Eriksson","sequence":"additional","affiliation":[]},{"given":"Markus","family":"Heilig","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2003,9,10]]},"reference":[{"key":"BF1300296_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0091-3057(01)00578-0","volume":"70","author":"C Arevalo","year":"2001","unstructured":"Arevalo C, de Miguel R, Hernandez-Tristan R (2001). Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters. Pharmacol Biochem Behav 70: 123\u2013131.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300296_CR2","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1111\/j.1460-9568.1997.tb01476.x","volume":"9","author":"L Caberlotto","year":"1997","unstructured":"Caberlotto L, Fuxe K, Sedvall G, Hurd YL (1997). Localization of neuropeptide Y Y1 mRNA in the human brain: abundant expression in cerebral cortex and striatum. Eur J Neurosci 9: 1212\u20131225.","journal-title":"Eur J Neurosci"},{"key":"BF1300296_CR3","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1097\/00001756-199906030-00022","volume":"10","author":"L Caberlotto","year":"1999","unstructured":"Caberlotto L, Hurd YL (1999). Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder. Neuroreport 10: 1747\u20131750.","journal-title":"Neuroreport"},{"key":"BF1300296_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0893-133X(00)00231-1","volume":"25","author":"L Caberlotto","year":"2000","unstructured":"Caberlotto L, Hurd YL (2000). Neuropeptide Y Y(1) and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Relationship of Y(2) subtype to suicidal behavior. Neuropsychopharmacology 25: 91\u201397.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300296_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/BF00402387","volume":"18","author":"EA Carlini","year":"1970","unstructured":"Carlini EA, Santos M, Claussen U, Bieniek D, Korte F (1970). Structure activity relationship of four tetrahydrocannabinols and the pharmacological activity of five semi-purified extracts of Cannabis sativa. Psychopharmacologia 18: 82\u201393.","journal-title":"Psychopharmacologia"},{"key":"BF1300296_CR6","doi-asserted-by":"publisher","first-page":"6340","DOI":"10.1523\/JNEUROSCI.15-10-06340.1995","volume":"15","author":"DT Chalmers","year":"1995","unstructured":"Chalmers DT, Lovenberg TW, De Souza EB (1995). Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15: 6340\u20136350.","journal-title":"J Neurosci"},{"key":"BF1300296_CR7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S0024-3205(99)00016-8","volume":"64","author":"J Corchero","year":"1999","unstructured":"Corchero J, Fuentes JA, Manzanares J (1999). Chronic treatment with CP-55,940 regulates corticotropin releasing factor and proopiomelanocortin gene expression in the hypothalamus and pituitary gland of the rat. Life Sci 64: 905\u2013911.","journal-title":"Life Sci"},{"key":"BF1300296_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0304-3940(91)90836-I","volume":"124","author":"J H\u00e4nze","year":"1991","unstructured":"H\u00e4nze J, Kummer W, Haass M, Lang RE (1991). Neuropeptide Y mRNA regulation in rat sympathetic ganglia: effect of reserpine. Neurosci Lett 124: 119\u2013121.","journal-title":"Neurosci Lett"},{"key":"BF1300296_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/0166-2236(94)90079-5","volume":"17","author":"M Heilig","year":"1994","unstructured":"Heilig M, Koob GF, Ekman R, Britton KT (1994). Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci 17: 80\u201385.","journal-title":"Trends Neurosci"},{"key":"BF1300296_CR10","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","volume":"87","author":"M Herkenham","year":"1990","unstructured":"Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC (1990). Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87: 1932\u20131936.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1300296_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF03179772","volume":"56","author":"R Hernandez-Tristan","year":"2000","unstructured":"Hernandez-Tristan R, Arevalo C, Canals S, Leret ML (2000). The effects of acute treatment with delta9THC on exploratory behaviour and memory in the rat. J Physiol Biochem 56: 17\u201324.","journal-title":"J Physiol Biochem"},{"key":"BF1300296_CR12","first-page":"65","volume":"6","author":"S Holm","year":"1979","unstructured":"Holm S (1979). A simple sequentially rejective multiple test procedure. Scand J Stat 6: 65\u201370.","journal-title":"Scand J Stat"},{"key":"BF1300296_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1046\/j.1471-4159.1999.0730493.x","volume":"73","author":"C Hsieh","year":"1999","unstructured":"Hsieh C, Brown S, Derleth C, Mackie K (1999). Internalization and recycling of the CB1 cannabinoid receptor. J Neurochem 73: 493\u2013501.","journal-title":"J Neurochem"},{"key":"BF1300296_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1749-6632.1999.tb07876.x","volume":"897","author":"GF Koob","year":"1999","unstructured":"Koob GF (1999). Stress, corticotropin-releasing factor, and drug addiction. Ann NY Acad Sci 897: 27\u201345.","journal-title":"Ann NY Acad Sci"},{"key":"BF1300296_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1126\/science.2903550","volume":"242","author":"GF Koob","year":"1988","unstructured":"Koob GF, Bloom FE (1988). Cellular and molecular mechanisms of drug dependence. Science 242: 715\u2013723.","journal-title":"Science"},{"key":"BF1300296_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0006-8993(99)01991-5","volume":"848","author":"GF Koob","year":"1999","unstructured":"Koob GF, Heinrichs SC (1999). A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res 848: 141\u2013152.","journal-title":"Brain Res"},{"key":"BF1300296_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","volume":"24","author":"GF Koob","year":"2001","unstructured":"Koob GF, Le Moal M (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24: 97\u2013129.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300296_CR18","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1111\/j.1460-9568.1993.tb00231.x","volume":"5","author":"PJ Larsen","year":"1993","unstructured":"Larsen PJ, Sheikh SP, Jakobsen CR, Schwartz TW, Mikkelsen JD (1993). Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system. Eur J Neurosci 5: 1622\u20131637.","journal-title":"Eur J Neurosci"},{"key":"BF1300296_CR19","first-page":"132","volume":"198","author":"DE McMillan","year":"1972","unstructured":"McMillan DE, Ford RD, Frankenheim JM, Harris RA, Harris LS (1972). Tolerance to active constituents of marihuana. Arch Int Pharmacodyn Ther 198: 132\u2013144.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"BF1300296_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/BF00427697","volume":"82","author":"AG Molloy","year":"1984","unstructured":"Molloy AG, Waddington JL (1984). Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390. Psychopharmacology 82: 409\u2013410.","journal-title":"Psychopharmacology"},{"key":"BF1300296_CR21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/cne.902900305","volume":"290","author":"BJ Morris","year":"1989","unstructured":"Morris BJ (1989). Neuronal localisation of neuropeptide Y gene expression in rat brain. J Comp Neurol 290: 358\u2013368.","journal-title":"J Comp Neurol"},{"key":"BF1300296_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0166-4328(93)90059-Y","volume":"57","author":"M Navarro","year":"1993","unstructured":"Navarro M, Fernandez-Ruiz JJ, de Miguel R, Hernandez ML, Cebeira M, Ramos JA (1993). An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity. Behav Brain Res 57: 37\u201346.","journal-title":"Behav Brain Res"},{"key":"BF1300296_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1527-3458.2001.tb00192.x","volume":"7","author":"A Ottani","year":"2001","unstructured":"Ottani A, Giuliani D (2001). Hu 210: a potent tool for investigations of the cannabinoid system. CNS Drug Rev 7: 131\u2013145.","journal-title":"CNS Drug Rev"},{"key":"BF1300296_CR24","volume-title":"The Rat Brain in Stereotaxic Coordinates","author":"G Paxinos","year":"1986","unstructured":"Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates 2nd edn. Academic Press: San Diego."},{"key":"BF1300296_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","volume":"14","author":"S Pellow","year":"1985","unstructured":"Pellow S, Chopin P, File SE, Briley M (1985). Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14: 149\u2013167.","journal-title":"J Neurosci Methods"},{"key":"BF1300296_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/0091-3057(86)90552-6","volume":"24","author":"S Pellow","year":"1986","unstructured":"Pellow S, File SE (1986). Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24: 525\u2013529.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300296_CR27","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1111\/j.1476-5381.1993.tb13989.x","volume":"110","author":"RG Pertwee","year":"1993","unstructured":"Pertwee RG, Stevenson LA, GRiffin G (1993). Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide. Br J Pharmacol 110: 1483\u20131490.","journal-title":"Br J Pharmacol"},{"key":"BF1300296_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","volume":"350","author":"M Rinaldi-Carmona","year":"1994","unstructured":"Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C et al (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350: 240\u2013244.","journal-title":"FEBS Lett"},{"key":"BF1300296_CR29","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1126\/science.276.5321.2050","volume":"276","author":"F Rodriguez de Fonseca","year":"1997","unstructured":"Rodriguez de Fonseca F, Carrera MRA, Navarro M, Koob GF, Weiss F (1997). Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276: 2050\u20132054.","journal-title":"Science"},{"key":"BF1300296_CR30","first-page":"56","volume":"276","author":"F Rodriguez de Fonseca","year":"1996","unstructured":"Rodriguez de Fonseca F, Rubio P, Menzaghi F, Merlo-Pich E, Rivier J, Koob GF et al (1996). Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats. J Pharmacol Exp Therap 276: 56\u201364.","journal-title":"J Pharmacol Exp Therap"},{"key":"BF1300296_CR31","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1097\/00001756-199412000-00022","volume":"5","author":"T Rubino","year":"1994","unstructured":"Rubino T, Massi P, Patrini G, Venier I, Giagnoni G, Parolaro D (1994). Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study. Neuroreport 5: 2493\u20132496.","journal-title":"Neuroreport"},{"key":"BF1300296_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0006-8993(96)00941-9","volume":"44","author":"T Rubino","year":"1997","unstructured":"Rubino T, Patrini G, Parenti M, Massi P, Parolaro D (1997). Chronic treatment with a synthetic cannabinoid CP-55,940 alters G-protein expression in the rat central nervous system. Brain Res Mol Brain Res 44: 191\u2013197.","journal-title":"Brain Res Mol Brain Res"},{"key":"BF1300296_CR33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1046\/j.1360-0443.2002.00026.x","volume":"97","author":"NT Smith","year":"2002","unstructured":"Smith NT (2002). A review of the published literature into cannabis withdrawal symptoms in human users. Addiction 97: 621\u2013632.","journal-title":"Addiction"},{"key":"BF1300296_CR34","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/0006-3223(94)00178-6","volume":"37","author":"N Solowij","year":"1995","unstructured":"Solowij N, Michie PT, Fox AM (1995). Differential impairments of selective attention due to frequency and duration of cannabis use. Biol Psychiatry 37: 731\u2013739.","journal-title":"Biol Psychiatry"},{"key":"BF1300296_CR35","first-page":"633","volume":"284","author":"DP Woldbye","year":"1997","unstructured":"Woldbye DP, Klemp K, Madsen TM (1997). Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal via Y5-like receptors. J Pharmacol Exp Therap 284: 633\u2013636.","journal-title":"J Pharmacol Exp Therap"},{"key":"BF1300296_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF00432554","volume":"76","author":"AW Zuardi","year":"1982","unstructured":"Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG (1982). Action of cannabidiol on the anxiety and other effects produced by delta 9THC in normal subjects. Psychopharmacology 76: 245\u2013250.","journal-title":"Psychopharmacology"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300296.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300296","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300296.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:44:59Z","timestamp":1684219499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["BF1300296"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300296","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9,10]]}}}